(Q73691647)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

1

D J Kereiakes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

T M Broderick

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D D Whang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Anderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Fye

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

633-634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900437-2

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900437-2

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900437-2

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900437-2

10.1016/S0002-9149(97)00437-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9294997%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference